流感疫苗的不良反应及其发生机制的研究进展
作者：张群慕;廖晓伟;
Author：
收稿日期： 年卷（期）页码：2016,31(03):-321-323
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：流感疫苗;不良反应;发生机制;免疫反应;体液免疫;安全性;因素
Key words：
基金项目：
中文摘要
接种流感疫苗是预防流感的发生及控制其传播的最有效手段之一。为提高流感疫苗的安全性和减少不良反应的发生,现综述了流感疫苗的不良反应及其发生机制。疫苗不良反应包括一般反应和异常反应,其中严重的不良反应包括格林-巴利综合征、过敏性紫癜和嗜睡症,可对人体产生较严重的损害。不良反应发生的原因较为复杂,可由外部因素和受种者身体和心理因素导致。流感疫苗不良反应的发生机制包括自身免疫反应、体液免疫、复合效应和分子模拟机制。
参考文献
[1]Wu J,Xu F,Lu L,et al.Safety and effectiveness of a 2009 H1N1vaccine in Beijing[J].N Engl J Med,2010,363(25):2416-2423.
[2]Salvatore C.Basophil activation test to optimize the diagnosis of adverse effects following immunization to vaccines[M].Tehran University of Medical Sciences,2013:12.
[3]Vellozzi C,Broder KR,Haber P,et al.Adverse events following influenza A(H1N1)2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System,United State,October 1,2009-January 31,2010[J].Vaccine,2010,28(45):7248-7255.
[4]Evans D,Cauchemez S,Hayden FG.“Prepandemic”immunization for novel influenza viruses,“swine flu”vaccine,GuillainBarre syndrome,and the detection of rare severe adverse events[J].J lnfect Dis,2009,200(3):32l-328.
[5]Schonberger LB,Bregman DJ,Sullvian-Bolyai JZ,et al.Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program,United States,1976-1977[J].Am J Epidemiol,1979,110:105-123.
[6]Centers for Disease Control and Prevention(CDC).Preliminary results:Surveillance for Guillain-Barre syndrome after receipt of influenza A(H1N1)2009 monovalent vaccine-United States,2009-2010[J].MMWR,2010,59:657-661.
[7]Haber P,Sejvar J,Mikaeloff Y,et al.Vaccines and GuilainBarre syndrome[J].Drug Saf,2009,32(4):309-323.
[8]包红红,李黎,武文娣,等.流行性感冒病毒疫苗不良反应文献复习[J].中国疫苗和免疫,2009,15(6):547-553.
[9]WHO.Statement on narcolepsy and vaccination[M].2011.http://www.who.int/vaccine_safety/topics/influenza/pandemic/h1n1_safety_assessing/narcolepsy_february2011/en/.
[10]Pritchard J,Hughes RA.Guillain-Barre syndrome[J].Lancet,2004,363(9427):2186-2188.
[11]Sivadon-Tardy V,Orlikowaki D,Porcher R,et al.GuillainBarre syndrome and influenza virus infection[J].Clin lnfec Dis,2009,48:48-56.
[12]Willison HJ.The immunobiology of Guillain-Barre syndromes[J].J Peripher Nerv Syst,2005,10:94-112.
[13]Nachamkin I,Shadomy SV,Moran AP,et al.Anti-ganglioside antibody induction by swine(A/NJ/1976/H1N1)and other influenza vaccines:Insights into vaccine-associated GuillainBarre syndrome[J].J Infect Dis,2008,198:226-233.
[14]Geier MR,Geier DA,Zahalsky AC.Influenza vaccination and Guillain-Barre syndrome[J].Clin lmmunol,2003,107:116-121.
[15]Ozen S,Pistorio A,Iusan S,et al.EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura,childhood polyarteritis nodosa,childhood Wegener granulomatosis and childhood Takayasu arteritis:Ankara 2008.PartⅡ:Final classification criteria[J].Ann Rheum Dis,2010,69(5):798-806.
[16]Lau KK,Suzuki H,Novak J,et al.Pathogenesis of HenochSchonlein purpura nephritis[J].Pediatr Nephrol,2010,25(1):19-26.
[17]Van Egmond M,Damen CA,Spriel AB,et al.Ig A and Ig A Fc receptor[J].Trends Immunol,2001,22(4):205-211.
[18]Li YY,Li CR,Wang GB,et al.Investigation of the change in CD4+T cell subset in children with Henoch-schonlein purpura[J].Rheumatol Int,2012,32(12):3785-92.
[19]Chen T,Guo ZP,Li MM,et al.Tumour necrosis factor-like weak inducer of apoptosis(TWEAK),an important mediator of endothelial in-flammation,is associated with the pathogenesis of Henoch-Schonlein purpum[J].Clin Exp Immunol,2011,166(1):64-71.
[20]Vaccines and immunization[EB/OL].(2011-02-01)[2011-02-15].http://www.euro.who.int/en/what-we-do/healthtopics/disease-prevention/vaccines-and-immunization/news/news/2012/02/pandemrix-vaccine-and-increased-riskof-narcolepsy.
[21]Kilpi T,Nohynek H.Increased risk of narcolepsy observed among children and adolescents vaccinated with PandemrixR[M].2011.
[22]Israeli E,Agmon-Levin N,B1ank M,et al.Guillain barre syndrome a classical autoimmune disease triggered by infection or vaccination[J].Clinic Rev Allerg Immunol,2012,42:121-130.
【关闭】
